Veracyte Inc. [VCYT] stock was sold by Holstein Jens at the price of US$0.14 million

0
4

In a filing, Veracyte Inc. revealed its Director Holstein Jens unloaded Company’s shares for reported $0.14 million on Jun 14. In the deal valued at $16.27 per share,8,720 shares were sold. As a result of this transaction, Holstein Jens now holds 2,000 shares worth roughly $ 48760.0.


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored


Then, Stapley Marc bought 60,000 shares, generating $980,094 in total proceeds. Upon buying the shares at $16.33, the Chief Executive Officer now owns 159,761 shares.

Before that, GORDON KEVIN K sold 15,000 shares. Veracyte Inc. shares valued at $277,502 were divested by the Director at a price of $18.50 per share. As a result of the transaction, GORDON KEVIN K now holds 8,720 shares, worth roughly $0.21 million.

Stephens initiated its Veracyte Inc. [VCYT] rating to an Overweight in a research note published on Friday, January 07, 2022; the price target was $52. PT values the company’s stock at a premium of 53.12 to its Friday closing price. Raymond James began covering VCYT with “an Outperform” recommendation on June 15, 2021.

Price Performance Review of VCYT

On Friday, Veracyte Inc. [NASDAQ:VCYT] saw its stock jump 0.62% to $24.38. On the same session, the stock had its day’s lowest price of $23.14, but rose to a high of $25.43. Over the last five days, the stock has gained 26.26%. Veracyte Inc. shares have fallen nearly -40.83% since the year began. Nevertheless, the stocks have fallen -53.56% over the past one year. While a 52-week high of $54.13 was reached on 01/03/22, a 52-week low of $14.85 was recorded on 05/12/22. SMA at 50 days reached $18.35, while 200 days put it at $22.44. A total of 1.44 million shares were traded, compared to the trading of 0.97 million shares in the previous session.

Levels Of Support And Resistance For VCYT Stock

The 24-hour chart illustrates a support level at 23.20, which if violated will result in even more drops to 22.03. On the upside, there is a resistance level at 25.49. A further resistance level may holdings at 26.61. The Relative Strength Index (RSI) on the 14-day chart is 73.01, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.97, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 9.99%. Stochastics %K at 86.08% indicates the stock is a selling.

How much short interest is there in Veracyte Inc.?

A steep rise in short interest was recorded in Veracyte Inc. stocks on Jul 14, 2022, growing by 0.28 million shares to a total of 3.91 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 3.63 million shares. There was a rise of 7.16%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 6.23% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.53.

Veracyte Inc. [VCYT] – Who Are The Largest Shareholders?

In filings from ARK Investment Management LLC, it is revealed that the company now owns 9,081,363 shares, or roughly 12.69% of the outstanding VCYT shares. In other words, the investor’s shares have risen by 225,118 from its previous 13-F filing of 8856245.0. Additionally, The Vanguard Group, Inc. increased 1.40% of its stake after which the total value it holdings stand at $109,352,600, while Wellington Management Co. LLP added 19.11% of its stake to hold $97.14 million in the firm. Over the last quarter, SSgA Funds Management, Inc. purchased 1,198,461 shares of Veracyte Inc., while BlackRock Fund Advisors bought 184,805 shares. At present, Invesco Advisers, Inc. is holding 3,885,557 shares valued at $64.5 million. Artisan Partners LP owned 3,841,439 shares of the company at the time of its most recent 13F filing, worth $63.77 million.

According to FactSet, Veracyte Inc.’s share price will average $30.17 in the next year, based on opinions of analysts polled by the firm. This is up nearly 30.0 percent from its previous closing price of $24.23. Analysts expect Veracyte Inc. stock to reach the higher price of $35.00, while the lowest price estimate is $22.00. However, 8 analysts have rated VCYT stock as an Overweight in their predictions for 2022. The most recent change occurred on January 28, 2021 when Truist began covering the stock and recommended ‘”a Buy”‘ rating along with a $61 price target.

LEAVE A REPLY

Please enter your comment!
Please enter your name here